Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib.

Katharina Pomej Lorenz BalcarBernhard ScheinerGeorg SemmlerTobias MeischlMattias MandorferThomas ReibergerChristian MüllerMichael TraunerMatthias Pinter

Published in: Journal of hepatocellular carcinoma (2021)

ABT was independently associated with worse outcomes in sorafenib-treated HCC patients. Prospective studies are needed to elucidate the underlying mechanism.

Keyphrases

newly diagnosed
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
metabolic syndrome
adipose tissue
mesenchymal stem cells
bone marrow
weight loss
patient reported
case control